annual CFI:
$52.59M+$184.09M(+140.00%)Summary
- As of today (May 29, 2025), BCRX annual cash flow from investing activities is $52.59 million, with the most recent change of +$184.09 million (+140.00%) on December 31, 2024.
- During the last 3 years, BCRX annual CFI has risen by +$36.79 million (+232.78%).
- BCRX annual CFI is now -32.52% below its all-time high of $77.93 million, reached on December 31, 2019.
Performance
BCRX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$27.09M+$9.30M(+52.24%)Summary
- As of today (May 29, 2025), BCRX quarterly cash flow from investing activities is $27.09 million, with the most recent change of +$9.30 million (+52.24%) on March 31, 2025.
- Over the past year, BCRX quarterly CFI has dropped by -$1.66 million (-5.78%).
- BCRX quarterly CFI is now -64.91% below its all-time high of $77.22 million, reached on December 31, 2022.
Performance
BCRX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$50.93M-$1.66M(-3.16%)Summary
- As of today (May 29, 2025), BCRX TTM cash flow from investing activities is $50.93 million, with the most recent change of -$1.66 million (-3.16%) on March 31, 2025.
- Over the past year, BCRX TTM CFI has increased by +$46.56 million (+1066.29%).
- BCRX TTM CFI is now -34.65% below its all-time high of $77.93 million, reached on December 31, 2019.
Performance
BCRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BCRX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +140.0% | -5.8% | +1066.3% |
| 3 y3 years | +232.8% | +170.4% | +236.4% |
| 5 y5 years | -32.5% | +152.7% | -30.0% |
BCRX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +140.0% | -64.9% | +125.3% | -3.2% | +123.5% |
| 5 y | 5-year | -32.5% | +140.0% | -64.9% | +125.3% | -30.0% | +123.5% |
| alltime | all time | -32.5% | +140.0% | -64.9% | +125.3% | -34.6% | +123.5% |
BCRX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $27.09M(+52.2%) | $50.93M(-3.2%) |
| Dec 2024 | $52.59M(-140.0%) | $17.80M(+109.6%) | $52.59M(+731.8%) |
| Sep 2024 | - | $8.49M(-446.6%) | $6.32M(-69.8%) |
| Jun 2024 | - | -$2.45M(-108.5%) | $20.95M(+379.8%) |
| Mar 2024 | - | $28.76M(-201.0%) | $4.37M(-103.3%) |
| Dec 2023 | -$131.50M(+2.5%) | -$28.47M(-223.2%) | -$131.50M(+409.5%) |
| Sep 2023 | - | $23.12M(-221.5%) | -$25.81M(-78.2%) |
| Jun 2023 | - | -$19.04M(-82.2%) | -$118.47M(-39.8%) |
| Mar 2023 | - | -$107.11M(-238.7%) | -$196.88M(+53.5%) |
| Dec 2022 | -$128.24M(-911.4%) | $77.22M(-211.0%) | -$128.24M(-40.8%) |
| Sep 2022 | - | -$69.54M(-28.6%) | -$216.57M(+55.5%) |
| Jun 2022 | - | -$97.44M(+153.3%) | -$139.28M(+273.0%) |
| Mar 2022 | - | -$38.47M(+246.0%) | -$37.34M(-336.3%) |
| Dec 2021 | $15.80M(-330.5%) | -$11.12M(-243.5%) | $15.80M(-67.3%) |
| Sep 2021 | - | $7.75M(+72.0%) | $48.34M(+640.4%) |
| Jun 2021 | - | $4.50M(-69.3%) | $6.53M(-324.6%) |
| Mar 2021 | - | $14.67M(-31.5%) | -$2.91M(-57.6%) |
| Dec 2020 | -$6.86M(-108.8%) | $21.41M(-162.9%) | -$6.86M(-42.9%) |
| Sep 2020 | - | -$34.06M(+590.6%) | -$12.01M(-126.4%) |
| Jun 2020 | - | -$4.93M(-146.0%) | $45.57M(-37.4%) |
| Mar 2020 | - | $10.72M(-34.1%) | $72.78M(-6.6%) |
| Dec 2019 | $77.93M(+1534.5%) | $16.26M(-30.8%) | $77.93M(+33.2%) |
| Sep 2019 | - | $23.51M(+5.5%) | $58.51M(+129.7%) |
| Jun 2019 | - | $22.28M(+40.3%) | $25.47M(+439.3%) |
| Mar 2019 | - | $15.88M(-601.5%) | $4.72M(-1.0%) |
| Dec 2018 | $4.77M(-107.4%) | -$3.17M(-66.8%) | $4.77M(-109.6%) |
| Sep 2018 | - | -$9.53M(-721.3%) | -$49.45M(+30.3%) |
| Jun 2018 | - | $1.53M(-90.4%) | -$37.96M(-39.6%) |
| Mar 2018 | - | $15.93M(-127.8%) | -$62.85M(-2.8%) |
| Dec 2017 | -$64.64M(-377.8%) | -$57.38M(-3023.3%) | -$64.64M(+278.4%) |
| Sep 2017 | - | $1.96M(-108.4%) | -$17.09M(-688.9%) |
| Jun 2017 | - | -$23.35M(-265.2%) | $2.90M(-91.6%) |
| Mar 2017 | - | $14.13M(-243.8%) | $34.70M(+49.1%) |
| Dec 2016 | $23.27M(-229.3%) | -$9.83M(-144.8%) | $23.27M(-22.7%) |
| Sep 2016 | - | $21.95M(+159.9%) | $30.11M(-401.8%) |
| Jun 2016 | - | $8.44M(+211.9%) | -$9.98M(-12.1%) |
| Mar 2016 | - | $2.71M(-190.6%) | -$11.35M(-37.0%) |
| Dec 2015 | -$18.00M(-55.0%) | -$2.99M(-83.5%) | -$18.00M(-73.6%) |
| Sep 2015 | - | -$18.14M(-356.5%) | -$68.11M(+51.0%) |
| Jun 2015 | - | $7.07M(-279.1%) | -$45.10M(+5.1%) |
| Mar 2015 | - | -$3.95M(-92.6%) | -$42.91M(+7.3%) |
| Dec 2014 | -$39.98M(+1053.2%) | -$53.09M(-1191.2%) | -$39.98M(-468.6%) |
| Sep 2014 | - | $4.87M(-47.5%) | $10.85M(+6205.8%) |
| Jun 2014 | - | $9.27M(-1005.8%) | $172.00K(-102.6%) |
| Mar 2014 | - | -$1.02M(-54.8%) | -$6.56M(+89.3%) |
| Dec 2013 | -$3.47M(-113.9%) | -$2.26M(-61.1%) | -$3.47M(-242.0%) |
| Sep 2013 | - | -$5.81M(-329.4%) | $2.44M(-87.7%) |
| Jun 2013 | - | $2.53M(+22.2%) | $19.93M(+29.2%) |
| Mar 2013 | - | $2.07M(-43.2%) | $15.42M(-38.0%) |
| Dec 2012 | $24.88M(+119.9%) | $3.65M(-68.8%) | $24.88M(+34.2%) |
| Sep 2012 | - | $11.68M(-690.5%) | $18.55M(-20.1%) |
| Jun 2012 | - | -$1.98M(-117.1%) | $23.21M(+53.7%) |
| Mar 2012 | - | $11.54M(-528.7%) | $15.10M(+33.4%) |
| Dec 2011 | $11.32M(+5021.3%) | -$2.69M(-116.5%) | $11.32M(-48.9%) |
| Sep 2011 | - | $16.34M(-262.0%) | $22.13M(+83.6%) |
| Jun 2011 | - | -$10.09M(-230.0%) | $12.05M(-50.6%) |
| Mar 2011 | - | $7.76M(-4.5%) | $24.39M(>+9900.0%) |
| Dec 2010 | $221.00K(-101.7%) | $8.12M(+29.8%) | $221.00K(-100.5%) |
| Sep 2010 | - | $6.26M(+178.6%) | -$40.93M(+4.5%) |
| Jun 2010 | - | $2.25M(-113.7%) | -$39.15M(+21.4%) |
| Mar 2010 | - | -$16.41M(-50.3%) | -$32.24M(+150.0%) |
| Dec 2009 | -$12.89M | -$33.03M(-510.8%) | -$12.89M(-141.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | $8.04M(-12.2%) | $31.03M(+58.7%) |
| Jun 2009 | - | $9.16M(+212.3%) | $19.56M(+44.0%) |
| Mar 2009 | - | $2.93M(-73.1%) | $13.58M(+19.2%) |
| Dec 2008 | $11.39M(-175.8%) | $10.90M(-417.4%) | $11.39M(+223.0%) |
| Sep 2008 | - | -$3.44M(-208.0%) | $3.53M(-120.9%) |
| Jun 2008 | - | $3.18M(+326.4%) | -$16.92M(-23.7%) |
| Mar 2008 | - | $746.00K(-75.4%) | -$22.18M(+47.5%) |
| Dec 2007 | -$15.03M(+20.4%) | $3.04M(-112.7%) | -$15.03M(+127.4%) |
| Sep 2007 | - | -$23.88M(+1046.3%) | -$6.61M(-151.5%) |
| Jun 2007 | - | -$2.08M(-126.4%) | $12.83M(+26.6%) |
| Mar 2007 | - | $7.89M(-31.1%) | $10.13M(-181.1%) |
| Dec 2006 | -$12.49M(+8.5%) | $11.46M(-358.2%) | -$12.49M(-57.4%) |
| Sep 2006 | - | -$4.44M(-7.2%) | -$29.32M(+46.1%) |
| Jun 2006 | - | -$4.78M(-67.6%) | -$20.07M(-9.5%) |
| Mar 2006 | - | -$14.73M(+174.0%) | -$22.18M(+92.7%) |
| Dec 2005 | -$11.51M(+305.9%) | -$5.38M(-211.6%) | -$11.51M(+417.3%) |
| Sep 2005 | - | $4.82M(-169.9%) | -$2.23M(-66.3%) |
| Jun 2005 | - | -$6.89M(+69.7%) | -$6.62M(-3816.3%) |
| Mar 2005 | - | -$4.06M(-203.8%) | $178.00K(-106.3%) |
| Dec 2004 | -$2.84M(-133.9%) | $3.91M(+811.9%) | -$2.84M(-26.0%) |
| Sep 2004 | - | $429.00K(-524.8%) | -$3.84M(-12.7%) |
| Jun 2004 | - | -$101.00K(-98.6%) | -$4.39M(-626.9%) |
| Mar 2004 | - | -$7.08M(-342.9%) | $834.00K(-90.0%) |
| Dec 2003 | $8.37M(-18.5%) | $2.91M(-2358.1%) | $8.37M(+18.6%) |
| Sep 2003 | - | -$129.00K(-102.5%) | $7.06M(-23.6%) |
| Jun 2003 | - | $5.13M(+1019.4%) | $9.23M(+84.3%) |
| Mar 2003 | - | $458.00K(-71.4%) | $5.01M(-51.2%) |
| Dec 2002 | $10.26M(-49.6%) | $1.60M(-21.8%) | $10.26M(-9.8%) |
| Sep 2002 | - | $2.05M(+126.2%) | $11.38M(-11.2%) |
| Jun 2002 | - | $905.00K(-84.2%) | $12.80M(-18.6%) |
| Mar 2002 | - | $5.71M(+110.5%) | $15.72M(-22.9%) |
| Dec 2001 | $20.38M(+1292.6%) | $2.71M(-21.9%) | $20.38M(+7.1%) |
| Sep 2001 | - | $3.48M(-9.1%) | $19.03M(+10.6%) |
| Jun 2001 | - | $3.82M(-63.2%) | $17.20M(+23.3%) |
| Mar 2001 | - | $10.37M(+663.4%) | $13.95M(+853.0%) |
| Dec 2000 | $1.46M(-103.1%) | $1.36M(-17.4%) | $1.46M(-103.3%) |
| Sep 2000 | - | $1.64M(+186.4%) | -$44.09M(-1.2%) |
| Jun 2000 | - | $574.00K(-127.2%) | -$44.64M(-7.4%) |
| Mar 2000 | - | -$2.11M(-95.2%) | -$48.21M(+1.1%) |
| Dec 1999 | -$47.70M(-922.4%) | -$44.20M(-4118.2%) | -$47.70M(+622.7%) |
| Sep 1999 | - | $1.10M(-136.7%) | -$6.60M(+78.4%) |
| Jun 1999 | - | -$3.00M(+87.5%) | -$3.70M(-254.2%) |
| Mar 1999 | - | -$1.60M(-48.4%) | $2.40M(-58.6%) |
| Dec 1998 | $5.80M(-43.1%) | -$3.10M(-177.5%) | $5.80M(-42.0%) |
| Sep 1998 | - | $4.00M(+29.0%) | $10.00M(+6.4%) |
| Jun 1998 | - | $3.10M(+72.2%) | $9.40M(+2.2%) |
| Mar 1998 | - | $1.80M(+63.6%) | $9.20M(-9.8%) |
| Dec 1997 | $10.20M(-137.5%) | $1.10M(-67.6%) | $10.20M(-169.9%) |
| Sep 1997 | - | $3.40M(+17.2%) | -$14.60M(-3.3%) |
| Jun 1997 | - | $2.90M(+3.6%) | -$15.10M(-30.7%) |
| Mar 1997 | - | $2.80M(-111.8%) | -$21.80M(-19.9%) |
| Dec 1996 | -$27.20M(-1107.4%) | -$23.70M(-917.2%) | -$27.20M(+209.1%) |
| Sep 1996 | - | $2.90M(-176.3%) | -$8.80M(-22.8%) |
| Jun 1996 | - | -$3.80M(+46.2%) | -$11.40M(+418.2%) |
| Mar 1996 | - | -$2.60M(-50.9%) | -$2.20M(-181.5%) |
| Dec 1995 | $2.70M(-131.4%) | -$5.30M(-1866.7%) | $2.70M(-64.0%) |
| Sep 1995 | - | $300.00K(-94.4%) | $7.50M(-13.8%) |
| Jun 1995 | - | $5.40M(+134.8%) | $8.70M(+480.0%) |
| Mar 1995 | - | $2.30M(-560.0%) | $1.50M(-117.4%) |
| Dec 1994 | -$8.60M | -$500.00K(-133.3%) | -$8.60M(+6.2%) |
| Sep 1994 | - | $1.50M(-183.3%) | -$8.10M(-15.6%) |
| Jun 1994 | - | -$1.80M(-76.9%) | -$9.60M(+23.1%) |
| Mar 1994 | - | -$7.80M | -$7.80M |
FAQ
- What is BioCryst Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual CFI year-on-year change?
- What is BioCryst Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly CFI year-on-year change?
- What is BioCryst Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM CFI year-on-year change?
What is BioCryst Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of BCRX is $52.59M
What is the all time high annual CFI for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual cash flow from investing activities is $77.93M
What is BioCryst Pharmaceuticals annual CFI year-on-year change?
Over the past year, BCRX annual cash flow from investing activities has changed by +$184.09M (+140.00%)
What is BioCryst Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of BCRX is $27.09M
What is the all time high quarterly CFI for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly cash flow from investing activities is $77.22M
What is BioCryst Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, BCRX quarterly cash flow from investing activities has changed by -$1.66M (-5.78%)
What is BioCryst Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of BCRX is $50.93M
What is the all time high TTM CFI for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM cash flow from investing activities is $77.93M
What is BioCryst Pharmaceuticals TTM CFI year-on-year change?
Over the past year, BCRX TTM cash flow from investing activities has changed by +$46.56M (+1066.29%)